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KEYWORDS	
	 Four	 new	 mixed	 ligand	 metal(II)	 complexes	 with	 1‐methylpyrazole‐3‐aldehyde‐4‐(2‐
pyridyl)thiosemicarbazone	 (MPAPT)	 and	 1,10‐phenanthroline	 are	 reported.	 These
complexes	 namely	 Cu(MPAPT)(1,10‐phen)(Cl)]	 (1),	 [Ni(MPAPT)(1,10‐phen)(Cl)]	 (2),
[Mn(MPAPT)(1,10‐phen)(Cl)].H2O	 (3)	 and	 [Co(MPAPT)(1,10‐phen)(Cl)].H2O	 (4),	 were
characterized	 by	 elemental	 analysis,	 spectral	 (IR,	 1H	 NMR	 and	 UV‐Vis)	 and	 magnetic
moment	measurements.	The	magnetic	and	spectral	data	 indicates	octahedral	structure
for	all	complexes.	Metal	complexes	have	been	modeled	using	parameterized	PM3	semi‐
empirical	method.	 The	 free	 ligand	 and	 its	M(II)	 chelates	have	 been	 screened	 for	 their
antimicrobial	 activities.	 The	 antimicrobial	 screening	 demonstrated	 that,	 the	 Cu(II)
complex	have	the	maximum	and	broad	activities	among	the	investigated	complexes.	
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1.	Introduction	
	
Thiosemicarbazones	have	been	extensively	studied	because	
they	 have	 a	 wide	 range	 of	 actual	 or	 potential	 medical	
applications	 [1‐6]	 which	 include	 notably	 antiparasital	 [5],	
antibacterial	[6]	antitumor	activities	[7],	antiviral	[8],	fungicidal	
[9]	and	antineoplastic	[10].	In	general,	thiosemicarbazones	are	
obtained	 by	 condensation	 of	 the	 corresponding	 thiosemi‐
carbazide	 with	 aldehydes	 or	 ketones.	 Thiosemicarbazones	
(TSCNs)	exist	 in	the	tautomeric	thione	(A)	and	thiol	(B)	forms	
(Scheme	1).		
	
	
	
Scheme	1	
		
The	chemistry	of	transition	metal	complexes	of	heterocyclic	
thiosemicarbazone	 ligands	 has	 been	 receiving	 considerable	
attention	 primarily	 because	 of	 their	 bioinorganic	 relevance	
[11,12].	There	have	been	attempts	[13]	to	determine	structural	
correlation’s	 between	 transition	 metal	 ion	 complexes	 of	
heterocyclic	 thiosemicarbazones	 and	 their	 wide	 spectrum	 of	
biological	 applications.	 In	 several	 cases,	 the	 pharmacological	
action	of	the	thiosemicarbazons	is	enhanced	due	to	their	ability	
to	chelate	transition	metal	ions	[14,15].	It	is	well	authenticated	
that	a	NNS	tridentate	system	is	present	in	most	of	the	thiosemi‐
carbazones	 having	 carcinostatic	 potency	 and	 possessing	
substantial	in	vitro	activity	against	various	human	tumour	lines	
[16,17].	In	the	past,	it	has	been	shown	that	the	metal	complexes	
are	 more	 effective	 than	 their	 parent	 ligands	 in	 anticancer	
activity	 [18,19].	 The	 inhibitory	 action	 of	 these	 compounds	 is	
attributed	 to	 their	 chelating	properties	 to	different	metal	 ions	
that	can	be	found	in	biological	systems,	which	microorganisms	
need	 in	 their	metabolism	 [20].	 Additionally,	 one	 of	 the	many	
reasons	 is	 that	 the	 binding	 affinity	 of	 metals	 to	 proteins	 or	
enzymes	will	change	the	interaction	process	of	them	with	DNA,	
thereby	 affecting	 the	 DNA	 replication	 and	 cell	 proliferation	
[19].	 Earlier	 studies	 on	 the	 biological	 properties	 of	
thiosemicarbazones	and	their	metal	complexes	have	concluded	
that	 the	 biologically	 active	 thiosemicarbazone	 molecules	 are	
planar	and	contain	a	pyridine	ring	or	derivatives	giving	rise	to	
NNS	tridentate	system	[21,22].		
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Scheme	2
	
	
1,10‐Phenanthroline	 (Scheme	 2)	 is	 the	 parent	 of	 an	
important	 class	 of	 chelating	 agents.	 The	 choice	 of	
phenanthroline	 is	 mainly	 due	 to	 two	 factors.	 This	
heteroaromatic	moiety	 can	 provide	 a	 further	 binding	 site	 for	
metal	cations.	 It	 is	 rigid,	and	provides	 two	aromatic	nitrogens	
whose	 unshared	 electron	 pairs	 can	 act	 co‐operatively	 in	
binding	 cations	 [23].	 The	 π‐electron	 deficiency	 makes	
phenanthroline	 an	 excellent	 π‐acceptor.	 Moreover,	 1,10‐
phenanthroline,	 the	 ligand	 moiety	 of	 the	 ternary	 complexes	
presented	 in	 this	 work	 is	 of	 considerable	 interest	 also	
according	 to	 the	 biological	 or	 pharmacological	 properties	
(antifungal,	antimycoplasma	and	antiviral)	of	some	of	its	metal	
complexes	 [24].	 With	 this	 in	 mind,	 it	 seems	 therefore	 of	
considerable	 interest	 to	 synthesize	 and	 characterize	 M(II)	
complexes	 with	 the	 novel	 1‐methylpyrazole‐3‐aldehyde‐4‐(2‐
pyridyl)thiosemicarbazone	 (MPAPT)	 and	 1,10‐phenanthroline	
(1,10‐phen)	with	different	bivalent	transition	metal	ions	Co(II),	
Cu(II),	Mn(II)	 and	Ni(II).	 Additionally,	 our	 objective	 is	 also	 to	
study	 the	 antibacterial,	 antifungal	 and	 antitumor	 activities	 of	
the	synthesized	compounds.		
	
2.	Experimental		
	
2.1.	Materials	and	instrumentation		
	
All	 starting	 materials	 were	 purchased	 from	 Fluka,	 Riedel	
and	Merck	and	used	as	received.	The	microchemical	analysis	of	
the	 separated	 solid	 compounds	 was	 carried	 out	 at	 the	
Department	 of	 Chemistry,	 Faculty	 of	 Science,	 King	 Abdul‐Aziz	
University,	 Jeddah,	21589,	KSA.	The	analyses	were	performed	
twice	 to	 check	 the	 accuracy	 of	 the	 analyses	 data.	 Infrared	
spectra	 were	 recorded	 on	 8001‐PC	 FT‐IR	 Shimadzu	
spectrophotometer	 using	 KBr	 pellets.	 The	 solid	 reflectance	
spectra	 were	 measured	 on	 a	 Shimadzu	 3101	 PC	 spectro‐
photometer.	 The	 room	 temperature	 magnetic	 susceptibility	
measurements	for	the	complexes	were	determined	by	the	Gouy	
balance	 using	 Hg[Co(SCN)4]	 as	 a	 calibrant.	 Electron	
paramagnetic	 resonance	 (EPR)	 has	 matured	 into	 a	 powerful,	
versatile,	non‐destructive,	and	non‐intrusive	analytical	method.	
EPR	 signals	 were	 recorded	 at	 room	 temperature	 by	 using	 a	
Bruker	 EMX	 spectrometer	 (X‐band)	 product	 of	 Bruker,	
Germany.	 The	 operating	 conditions	 are,	 microwave	 power	 =	
0.201	 mW,	 modulation	 amplitude	 =	 4.00	 Gauss,	 modulation	
frequency	 =	 100	 kHz,	 sweep	 width	 =	 200	 Gauss,	 microwave	
frequency	 =	 9.775	 GHz,	 time	 constant	 =	 81.92	ms	 and	 sweep	
time	=	20.97	s.	The	detection	limits	of	EPR	technique	depends	
on	 the	 type	 of	 sample,	 sample	 size,	 detector	 sensitivity,	
frequency	of	the	incident	microwave	radiation.	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	4‐(2‐pyridyl)‐3‐thiosemicarbazone		
	
4‐(2‐Pyridyl)‐3‐thiosemicarbazone	 is	 prepared	 in	 three	
steps	as	follow	(Scheme	2).	
Step	 1:	 Preparation	 of	 triethylammonium	N‐2‐pyridyldithio	
carbamate:	 2‐Aminopyridine	 (0.3	 mol,	 27.5	 g),	 carbon	
disulphide	(0.3	mol,	18	mL)	and	triethylamine	(0.3	mol,	45	mL)	
were	warmed	 to	 give	 a	 clear	 solution.	 Two	 phases	 separated	
rapidly	 and	 the	 whole	 mixture	 was	 shaken	 at	 room	
temperature	 for	 24	 h,	 the	 whole	 had	 then	 solidified.	 The	
product	was	filtered	and	then	washed	with	ether	and	air‐dried.	
The	lemon‐yellow	plates	formed	were	triethylammonium	N‐2‐
pyridyldithiocarbamate,	M.p.:	85	oC.		
Step	 2:	 Preparation	 of	 methyl‐2‐pyridyldithiocarbamate:	
Methanol	 (100	 mL)	 was	 added	 to	 triethylammonium	 N‐2‐
pyridyldithiocarbamate	(49.0	g,	0.18	mol),	 followed	by	methyl	
iodide	 (13	mL,	 0.2	mol).	 After	 1	 h,	water	was	 added	 into	 the	
solution	 and	 pale	 yellow	 needles	 of	 methyl‐2‐pyridyldithio	
carbamate	were	formed,	M.p.:	101	oC.		
Step	 3:	 Preparation	 of	 4‐(2‐pyridyl)‐3‐thiosemicarbazide:	 A	
mixture	 of	 0.26	 mol	 (50.0	 g)	 of	 methyl‐2‐pyridyldithio	
carbamate	and	26	mL	(0.80	mol)	of	hydrazine	hydrate	in	20	mL	
of	 absolute	 ethanol	 was	 heated	 for	 10	 min.	 An	 abundant	
amount	 of	 crystalline	 precipitate	 of	 4‐(2‐pyridyl)‐3‐thiosemi	
carbazide	was	formed,	M.p.:	193	°C.	Anal.	calcd.	for	C6H8N4S:	C,	
42.84;	H,	4.79;	N,	33.31.	Found:	C,	42.30;	H,	4.62;	N,	33.10%.	
	
2.2.2.	Synthesis	of	1‐methylpyrazole‐3‐aldehyde‐4‐(2‐
pyridyl)thiosemicarbazone	(MPAPT)	
	
The	general	route	of	synthesis	(Scheme	3)	is	shown	in	the	
following:	 Equimolar	 amounts	 of	 4‐(2‐pyridyl)‐3‐
thiosemicarbazone	 (0.1682	 g,	 1	mmol)	 in	25	mL	ethanol	with	
an	 ethanolic	 solution	 (25	 mL)	 of	 1‐methyl‐1‐H‐pyrazole‐5‐
carboxaldehyde	 (0.110	 g,	 1	mmol).	 The	 reaction	mixture	was	
then	refluxed	on	a	hot	plate	for	2‐3	h.	The	obtained	precipitates	
were	separated	out,	filtered	off,	washed	with	diethyl	ether	and	
dried	 overnight	 under	 silica	 gel.	 The	 proposed	 chemical	
structure	of	the	prepared	thiosemicarbazone	compound	is	in	a	
good	agreement	with	the	stoichiometries	concluded	from	their	
analytical	 data	 and	 confirmed	 by	 the	 IR	 spectral	 data.	 FT‐IR	
(KBr,	 ν,	 cm‐1):	 3188	 (νN1H),	 3168	 (νN2H),	 1648	 (νC=Nazomethine),	
1549	 (νC=Npyridine),	 1300,	 825	 (νC=S),	 1068	 (νN‐N),	 622	
(δC=Npyridine).	 Anal.	 calcd.	 for	 C11H12N6S:	 C,	 50.75;	 H,	 4.65;	 N,	
32.28.	Found:	C,	50.90;	H,	4.70;	N,	32.38%.	
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Scheme	3	
	
	
2.2.3.	Synthesis	of	thiosemicarbazone	complexes		
	
All	 complexes	 were	 prepared	 by	 refluxing	 an	 ethanolic	
solution	 of	 the	 thiosemicarbazone	 (MPAPT)	 ligand	 (1	 mmol)	
and	 1,10‐phenanthroline	 heterocyclic	 base	 (1	 mmol)	 with	 an	
ethanolic	 solution	 of	 metal	 salt	 (1	 mmol)	 in	 the	 molar	 ratio	
1:1:1.	The	reaction	mixtures	were	refluxed	on	a	water	bath	for	
4	 h	 and	 allowed	 to	 cool	 to	 room	 temperature	 overnight.	 The	
precipitated	 complexes	 were	 then	 filtered	 off,	 washed	 with	
petroleum	ether	and	dried	overnight	in	a	vacuum	desiccator.	
[Cu(MPAPT)(1,10‐phen)(Cl)]	complex	(1):	Yield:	77	%.	FT‐IR	
(KBr,	 ν,	 cm‐1):	 3208	 (νN1H),	 1602	 (νC=Nazomethine),	 1591	 (νN=C),	
1525	 (νC=Npyridine),	 1279,	 825	 (νC=S),	 1070	 (νN‐N),	 615	
(δC=Npyridine),	452	(νM‐N),	275	(νM‐Npy),	343	(νM‐S),	250	(νM‐Cl).	Anal.	
calcd.	 for	C23H19N8SCuCl:	C,	51.30;	H,	3.56;	N,	20.81.	Found:	C,	
51.21;	H,	3.46;	N,	20.70%.	
[Ni(MPAPT)(1,10‐phen)(Cl)]	complex	(2):	Yield:	73	%.	FT‐IR	
(KBr,	 ν,	 cm‐1):	 3215	 (νN1H),	 1608	 (νC=Nazomethine),	 1581	 (νN=C),	
1527	 (νC=Npyridine),	 1270,	 810	 (νC=S),	 1070	 (νN‐N),	 612	
(δC=Npyridine),	448	(νM‐N),	340	(νM‐S),	283	(νM‐Npy),	248	(νM‐Cl).	Anal.	
calcd.	 for	C23H19N8SNiCl:	 C,	 51.76;	H,	 3.59;	N,	21.00.	 Found:	 C,	
51.71;	H,	3.46;	N,	21.01%.	
[Co(MPAPT)(1,10‐phen)(Cl)].H2O	 complex	 (3):	 Yield:	 70	%.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	 3220	 (νN1H),	 1601	 (νC=Nazomethine),	 1580	
(νN=C),	 1530	 (νC=Npyridine),	 1268,	 805	 (νC=S),	 1082	 (νN‐N),	 613	
(δC=Npyridine),	455	(νM‐N),	340	(νM‐S),	287	(νM‐Npy),	255(νM‐Cl).	Anal.	
calcd.	for	C23H19N8SCoCl.H2O:	C,	50.05;	H,	3.84;	N,	20.31.	Found:	
C,	50.01;	H,	3.76;	N,	20.27%.	
[Mn(MPAPT)(1,10‐phen)(Cl)].H2O	complex	 (4):	Yield:	77	%.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	 3222	 (νN1H),	 1610	 (νC=Nazomethine),	 1575	
(νN=C),	 1529	 (νC=Npyridine),	 1271,	 811	 (νC=S),	 1080	 (νN‐N),	 611	
(δC=Npyridine),	448	(νM‐N),	345	(νM‐S),	290	(νM‐Npy),	263	(νM‐Cl).	Anal.	
calcd.	 for	 C23H19N8SMnCl.H2O:	 C,	 50.42;	 H,	 3.86;	 N,	 20.45.	
Found:	C,	50.38;	H,	3.43;	N,	20.38%.	
	
2.3.	Molecular	modeling	
	
An	 attempt	 to	 gain	 a	 better	 insight	 on	 the	 molecular	
structure	 of	 these	 synthesized	 thiosemicarbazone	 compounds	
and	 their	 M(II)‐complexes,	 geometric	 optimization	 and	
conformation	 analysis	 has	 performed	 using	 semiempirical	
parameterized	PM3	method	as	implemented	in	HyperChem	7.5	
[25].	Convergence	criteria	were	set	to	0.01	kcal/mol.Å	for	PM3	
calculations.	
	
2.4.	Biological	activity	
	
2.4.1.	Antibacterial	and	antifungal	activities	
	
The	antibacterial	 investigation	of	 the	 free	 (MPAPT)	 ligand	
or	its	Mn(II),	Co(II),	Cu(II)	and	Ni(II)	complexes	was	carried	out	
using	 a	modified	Kirby‐Bauer	disc	 diffusion	method	 [26].	 The	
test	was	 done	 against	 filamentous	 fungi	 as	 (Aspergillus	 flavus	
(RCMB	 02568),	 Pencicillium	 italicum	 (RCMB	 03924),	 and	
Aspergillus	 flavus	 (RCMB	 02568))	 at	 30	 °C	 for	 24‐48	 hours;	
Gram	 (+)	 bacteria	 as	 (Bacillus	 subtillis	 RCMB	 010067	 and	
Staphylococcus	 aureus	 RCMB	 010028);	 Gram	 (‐)	 bacteria	 as	
(Pseudomonas	 aeuroginosa	 (RCMB	 010043),	 and	 Escherichia	
coli	 (RCMB	 010052)).	 The	 standard	 antibacterial	 agents	 used	
are	 Gentamicin	 for	 Gram‐,	 Ampicillin	 for	 Gram+	 and	
Amphotericin	B	 (Antifungal	 agent)	 served	 as	 positive	 controls	
while	 DMSO,	 which	 exhibited	 no	 antimicrobial	 activity,	 was	
used	 as	 a	 negative	 control.	 The	 agar	 used	 is	 Mueller‐Hinton	
agar	 that	 is	 rigorously	 tested	 for	 composition	 and	 pH.	 Plates	
were	incubated	with	filamentous	fungi	at	30	°C	for	24‐48	hours	
and	with	bacteria	at	35‐37	°C	for	24‐48	hours	[27]	and	then	the	
diameters	 of	 inhibition	 zones	 were	 measured	 in	 millimeters	
using	 slipping	 calipers	 of	 the	 National	 Committee	 for	 Clinical	
Laboratory	Standards	(NCCLS)	[28,29].		
	
2.4.2.	In	vitro	cytotoxicity	
	
The	 synthesized	M(II)	 complexes	were	 screened	 for	 their	
cytotoxicity	 against	 colon	 carcinoma	 (HCT116)	 and	 larynx	
carcinoma	(HEP2)	cells	by	using	the	protocol	of	SRB	assay	[30].	
Cells	were	plated	in	96‐multiwell	plate	(104	cells/well)	for	24	h	
before	 treatment	with	 the	 compounds	 to	 allow	 attachment	 of	
cells	 to	 the	 wall	 of	 plate.	 Different	 concentrations	 of	 the	 test	
chemical	 compound	 were	 added	 to	 the	 cell	 monolayer.	
Triplicate	 wells	 were	 prepared	 for	 each	 individual	 dose	 and	
IC50	is	the	mean	of	three	values.	Monolayer	cells	were	incubated	
for	48	h	at	37	°C	in	air	with	5	%	CO2.	After	48	h,	cells	were	fixed,	
washed	and	stained	with	Sulfo‐Rhodamine‐B	stain.	Excess	stain	
was	washed	with	acetic	acid	and	attached	stain	was	recovered	
with	tris‐EDTA	buffer.	Color	intensity	is	measured	in	an	ELISA	
reader.	 The	 average	 drug	 concentration	 (µg/cm3)	 for	 50	 %	
inhibition	of	tumor	cell‐growth	was	determined	by	plotting	the	
surviving	 fraction	 versus	 drug	 concentration	 for	 each	 tumor	
cell	line.		
	
3.	Results	and	discussion	
	
The	isolated	thiosemicarbazone	compound	is	formed	by	the	
interaction	 of	 4‐(2‐pyridyl)‐3‐thiosemicarbazone	 with	 1‐
methyl‐1H‐pyrazole‐5‐carboxaldehyde	 in	 a	 molar	 ratio	 1:1	
under	 reflux	 conditions	 (Scheme	 3).	 The	 formulation	 of	 the	
isolated	 compounds	 based	 on	 the	 elemental	 analysis,	 IR,	 and	
electronic	 spectra.	 The	 solid	 compounds	 are	 air	 stable.	 These	
compounds	 are	 colored,	 insoluble	 in	 H2O	 and	 other	 common	
organic	 solvents	 like	 methanol	 and	 ethanol	 but	 soluble	 in	
dimethylformamide	 (DMF)	 and	 dimethylsulphoxide	 (DMSO).	
Attempts	 to	 obtain	 single	 crystal	 suitable	 for	 X‐ray	
determination	were	unsuccessful,	thus	molecular	modeling	for	
MPAPT	thiosemicarbazone	compound	and	 its	M(II)‐complexes	
were	investigated.		
	
3.1.	Infrared	spectra	
	
The	 characteristic	 IR	 peaks	 of	 the	 free	 MPAPT	
thiosemicarbazone	 compound	 and	 its	 metal(II)	 complexes	
reveal	 each	 of	 the	 following:	 The	 stretching	 vibrations	 of	
azomethine	functionality	ν(C=N)	was	observed	near	1648	cm‐1.	
The	 lower	 shift	 of	 ν(C=N)	 stretching	 vibration	 of	 the	
azomethine	in	the	complexes	indicating	the	participation	of	the	
azomethine	 nitrogen	 in	 coordination	 [31].	 The	 ν(N‐N)	 of	 the	
thiosemicarbazone	ligand	is	found	at	1068	cm‐1.	The	increase	in	
frequency	of	 this	band	 in	 the	spectra	of	 complexes	due	 to	 the	
increase	 in	 the	 double	 bond	 character	 of	 N‐N	 [32]	 is	 an	
evidence	 for	 the	 enethiolization	 of	 the	 thiosemicarbazone	
ligand	 and	 the	 coordination	 via	 the	 azomethine	nitrogen.	 The	
ν(N1H)	and	hydrazine	ν(N2H)	were	observed	at	3188	and	3168	
cm‐1.	 The	 pyridine	 in‐plane	 deformation	mode	 at	 622	 cm‐1	 in	
the	spectrum	of	the	ligand	shifts	to	611‐615	cm‐1	in	spectra	of	
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the	 above	 complexes,	 suggesting	 coordination	 of	 the	
heteroaromatic	 nitrogen.	 In	 the	 spectra	 of	 all	 complexes,	 the	
bands	 assigned	 to	 the	 newly	 formed	 (N=C)*	 band	 due	 to	 the	
thiolating	 of	 the	 (C=S)	 groups	 are	 located	 in	 the	 range	 1575‐
1591	cm‐1.	The	IR	spectrum	of	the	free	1,10‐phen	ligand	shows	
a	 very	 stronger	 bands	 at	 ~1570	 cm‐1	 due	 to	 stretching	
frequency	of	>C=N	present	in	1,10‐phenanthroline	moiety.	This	
band	was	shifted	to	lower	frequencies	in	the	complexes	~25‐28	
cm‐1,	 which	 clearly	 indicate	 that	 the	 coordination	 of	 the	 two	
nitrogen	 atoms	 of	 the	 neutral	 1,10‐phen	 ligand	 to	 M(II)	 ion	
upon	complexation	[33].	In	the	ligand	spectra,	the	strong	band	
observed	 in	 the	 range	 1549	 cm‐1	 is	 assigned	 to	 ν(C=N)	
stretching	 vibration	 [34]	 of	 pyridine	 ring.	 In	 the	 spectra	 of	
complexes,	this	band	was	not	observed	at	the	same	frequencies	
and	the	same	intensities.	 It	shifted	after	coordination	to	lower	
energies	 by	 ca.	 19‐24	 cm‐1,	 indicating	 coordination	 via	
azomethine	 nitrogen	 [35].	 The	 coordination	 positions	 of	 the	
MPAPT	 thiosemicarbazone	 in	 the	 M(II)	 complexes	 are	
confirmed	by	assigning	the	strong	bands	observed	in	the	far	IR	
spectra	of	the	complexes.	The	bands	observed	at	448‐455	and	
340‐345	 cm‐1	 are	 assigned	 to	 ν(M‐N)	 [36]	 and	 ν(M‐S)	 as	
suggested	by	Lever	[37],	respectively.	The	broad	band	centered	
at	 3460‐3490	 cm‐1	 in	 the	 spectra	 of	 both	 Co(II)	 and	 Mn(II)	
complexes	may	be	due	to	hydrated	water.	In	the	literature,	the	
bands	appearing	between	160	and	300	cm‐1	are	allotted	to	the	
vibration	of	 the	M‐X	bonds	where	M	=	metal	and	X	=	Cl	or	Br	
[38,39].	In	our	case	the	ν(M‐Cl)	frequencies	appearing	between	
248‐263	cm‐1	are	 in	good	agreement	with	the	reported	values	
in	 the	 literature.	 Based	 on	 the	 above	 spectral	 evidences,	 it	 is	
confirmed	 that	 the	 thiosemicarbazone	 ligands	 lost	 the	 N2	
proton	 and	 coordinated	 to	 the	 M(II)	 ion	 as	 mononegative	
tridentate	anion,	coordinating	via	the	azomethine	and	pyridine	
nitrogen	 atoms	 and	 the	 thiolate	 sulfur	 atom	 after	
deprotonation.		
	
3.2.	Electronic	spectra		
	
The	 probable	 assignments	 for	 the	 bands	 in	 the	 region	
27345	 and	 32989	 cm‐1	 are	 due	 to	 the	 n	 →	 π*	 and	 π	 →	 π*	
transitions	 of	 thiosemicarbazone	 compound	 respectively.	
Always	n	→	π*	transitions	occurs	at	a	lower	energy	than	π	→	π*	
transitions	 [40].	 In	 the	 spectra	 of	 M(II)	 complexes	 the	 bands	
observed	in	the	region	26521‐26920	cm‐1	are	assigned	to	S→M	
charge‐transfer	 band	 [41].	 The	 bands	 in	 the	 range	 30870‐
31108	cm‐1	observed	 in	 the	spectra	of	all	M(II)	complexes	are	
assigned	as	Cl	→	M	charge‐transfer	transitions	[42].	The	shift	of	
the	π	→	π*	bands	to	the	longer	wavelength	region	is	the	result	
of	the	C=S	bond	being	weakened	and	conjugation	system	being	
enhanced	after	the	formation	of	the	complex	[43].	The	magnetic	
moment	of	Mn(II)	complex	(6.01	B.M.)	is	corresponding	to	five	
unpaired	electrons,	as	expected	for	high	spin	3d5	systems	[44].	
The	 electronic	 spectrum	 of	 this	 complex	 show	 two	 bands	 at	
20850	and	24120	cm‐1	attributable	to	6A1g	→	6T1g(G)	and	6A1g	→	
6T2g(G),	respectively,	suggesting	an	octahedral	structure	[44].		
The	 Co(II)	 complexes	 generally	 give	 rise	 to	 three	
absorption	 bands	 in	 the	 visible	 region	 under	 the	 influence	 of	
the	 octahedral	 field	by	 the	excitation	of	 the	electron	 from	 the	
ground	state	4T1g	(F)	to	the	excited	states	4T2g	(F),	4A2g	(F)	and	
4T1g	(P).	In	the	Co(II)	complex,	only	two	bands	are	observed	at	
9935	 cm–1	 4T1g(F)	 →	 4T2g(F)	 (1)	 and	 20,423	 cm–1	 4T1g(F)	 →	
4T1g(P)	 (3)	 as	 reported	 in	 many	 octahedral	 cobalt(II)	
complexes	 [45,46].	 The	ν2	 transition	was	not	observed	due	 to	
very	weak	 intensity.	 The	 value	 of	 the	magnetic	moment	 4.71	
B.M.	 (normal	 range	 for	 octahedral	 Co(II)	 complexes	 is	 4.3‐5.2	
B.M.)	is	additional	evidence	for	an	octahedral	geometry	around	
the	Co(II)	ion	[47].	
The	 copper(II)	 complex	 exhibit	 magnetic	moment	 of	 1.82	
B.M.	at	room	temperature.	This	value	is	quite	close	to	the	spin	
allowed	 values	 expected	 for	 a	 S	 =	 1/2	 system	 and	 may	 be	
indicative	of	a	distorted	octahedral	geometry	around	copper(II)	
ion.	 This	 copper(II)	 complex	 displays	 a	 broad	 band	 at	 14585	
cm‐1	due	to	2B1g	→	2Eg	assigned	to	d‐d	transitions	of	a	distorted	
octahedral	environment	[48,49].		
The	electronic	spectra	of	the	nickel(II)	complexes	exhibited	
absorption	bands	at	10675	and	17540	cm‐1,	attributable	to	3A2g	
→	 3T1g(F)	 and	 3A2g	 →	 3T1g(P),	 transitions,	 respectively,	 in	 an	
octahedral	 geometry	 [45,49].	 Also,	 the	 value	 of	 the	 magnetic	
moment	 (3.21	 B.M.)	may	 be	 taken	 as	 additional	 evidence	 for	
their	 octahedral	 structure.	 On	 the	 basis	 of	 the	 above	
observations,	 it	 is	 tentatively	 suggested	 that	 all	 of	 the	
complexes	show	an	octahedral	geometry	 in	which	 the	MPAPT	
thiosemicarbazone	 ligand	 act	 as	monoanion	 tridentate	 ligand,	
1,10‐phen	 acts	 as	 bidentate	 ligand	 and	 in	 addition	 to	 the	
monodentate	 chloride	 ion.	 These	 possibly	 accommodate	
themselves	around	the	metal	atom	in	such	a	way	that	a	stable	
chelate	 ring	 is	 formed	 giving,	 in	 turn,	 stability	 to	 the	 metal	
complexes.	
	
3.3.	ESR	spectrum	of	[Cu(MPAPT)(1,0‐phen)Cl]	complex	
	
ESR	spectroscopy	is	a	direct	measurement	of	electron	spin	
when	there	are	unpaired	electrons	within	a	chemical	structure	
and	thus	provides	a	way	to	investigate	the	electronic	spin	state	
and	oxidation	state	of	the	coordinated	metal	ion.	Also,	the	ESR	
spectra	of	the	complexes	is	important	in	studying	the	metal	ion	
environment	 in	 the	 complexes,	 such	 as	 geometry,	 nature	 of	
ligation	 sites	 from	 the	 ligand	 to	 the	metal,	 and	 the	 degree	 of	
covalence	 of	 the	 metal‐ligand	 bonds.	 The	 room	 temperature	
powder	 ESR	 spectrum	 of	 [Cu(MPAPT)(1,10‐phen)Cl]	 exhibits	
an	axial	signal	with	two	g	values	(g||	=	2.140,	g┴	=	2.031).	The	g||	
and	g┴	values	are	computed	from	the	spectrum	using	DPPH	free	
radical	as	"g"	marker.	The	ordering	of	g	values	(g||	>	g┴	>	2.003)	
observed	 for	 copper(II)	 complex	 indicates	 that	 the	 unpaired	
electron	 is	 localized	 in	 (dx2‐y2)	 orbital	 [50]	 of	 the	 Cu(II)	 ion	
(spectroscopic	 state	 2B1g)	 and	 the	 spectral	 features	 are	
characteristics	 of	 axial	 symmetry	 [51].	 g||	 is	 a	 moderately	
sensitive	 function	 for	M‐L	 bond	 nature.	 Kivelson	 and	Neiman	
[40]	have	reported	the	g||	value	<	2.3	for	covalent	character	of	
metal‐ligand	 bond	 and	 g||	 value	 >	 2.3	 for	 ionic	 character.	 By	
applying	 this	 criterion,	 the	 g||	 value	 is	 less	 than	 2.3	 is	 an	
indication	 of	 significant	 covalent	 bonding	 in	 copper(II)	
complex.	 Based	 on	 elemental	 analysis,	 IR,	 electronic	 spectra	
and	 ESR	 data,	 Cu(II)	 complex	 has	 octahedral	 structure.	 The	
geometric	 parameter	 G,	 which	 is	 a	 measure	 of	 the	 exchange	
interaction	 between	 copper	 centers	 in	 the	 polycrystalline	
compound,	 is	 calculated	 using	 Hathway	 expression	 (G	 =	 g||‐
2.0023/g┴‐2.0023)	[52].	According	to	Hathway,	if	the	value	of	G	
>	 4,	 the	 exchange	 interaction	 is	 negligible	 in	 solid	 complexes	
but	G	<	4	indicates	considerable	interaction	in	solid	complexes.	
In	the	Cu(II)	complex	reported	in	this	paper	the	G	value	(4.797)	
>	 4,	 suggesting	 the	 absence	 of	 copper‐copper	 exchange	
interactions	in	the	solid	state.		
		
3.4.	Conductivity	measurements	
	
Conductivity	measurements	in	non‐aqueous	solutions	have	
frequently	 been	 used	 in	 structural	 studies	 of	 metal	 chelates	
within	the	limits	of	their	solubility.	These	measurements	were	
provided	 a	method	 for	 testing	 the	 degree	 of	 ionization	 of	 the	
complexes,	the	molar	ions	that	a	complex	liberates	in	solution,	
the	 higher	 will	 be	 its	molar	 conductivity	 and	 vice	 versa.	 The	
non‐ionized	 complexes	 have	 negligible	 value	 of	 molar	
conductance.	 It	 is	 clear	 from	 the	 conductivity	 data	 (Table	 1)	
that	 the	 complexes	 present	 seem	 to	 be	 nonelectrolytes	 (2.01‐
3.81	Ω‐1.cm2.mol‐1).	Also	the	molar	conductance	values	indicate	
that	 the	 anions	 were	 existed	 inside	 the	 coordination	 sphere	
which	was	also	confirmed	from	the	chemical	analysis	and	also	
Cl‐	ion	is	not	precipitated	by	addition	of	AgNO3	solution.	Hence,	
the	 conductivity	 measurements	 of	 the	 metal(II)‐chelates	
confirm	 the	 proposed	 general	 formulae	 of	 those	 chelates	 as	
suggested	 depending	 upon	 the	 results	 of	 elemental	 analyses,	
UV‐Vis,	ESR	and	IR	spectra.	
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Table	1.	Molar	conductance,	magnetic	moment	and	electronic	spectral	data	(cm‐1)	of	the	complexes.	
Compounds	 ΛM	a	 µeff.	(B.M.)	 d‐d	 Transitions	
[Cu(MPAPT)(1,10‐phen)Cl]	(1)	 2.01	 1.82 14585 2B1g→2Eg	
[Ni(MPAPT)(1,10‐phen)Cl]	(2)		 2.54	 3.21 10675
17540	
3A2g→3T1g(F)	
3A2g→3T1g(P)	
[Co(MPAPT)(1,10‐phen)Cl].H2O	(3)	 3.15	 4.71 9935
20423	
4T1g(F)4T2g(F)	
4T1g(F)4T1g(P)	
[Mn(MPAPT)(1,10‐phen)Cl].H2O	(4)	 3.81	 6.01 20850
24120	
6A1g	→	6T1g(G)	
6A1g	→	6T2g(G)	
a	Molar	conductance	measured	for	10‐3	M	DMSO	solution,	Ω‐1	cm2	mol‐1.	
	
	
Table	2.	Antibacterial	activity	of	thiosemicarbazone	ligand	and	its	metal	complexes.	
Compounds	 	 Diameter	of	inhibition	zone	(in	mm) a
G(‐)	 G(+)	
Pseudomonas	aeuroginosa
(RCMB	010043)	
Escherichia	coli
(RCMB	010052)	
Bacillus	subtillis
(RCMB	010067)	
Staphylococcus	aureus
(RCMB	010028)	
MPAPT	 13.2±0.34	 ‐	 19.4±0.44	 18.1±0.25	
[Cu(MPAPT)(1,10‐phen)Cl]	(1)	 17.7±0.19	 14.1±0.37	 24.7±0.52	 27.2±0.45	
[Ni(MPAPT)(1,10‐phen)Cl]	(2)		 15.4±0.22	 12.2±0.14 21.5±0.42 24.7±0.14	
[Co(MPAPT)(1,10‐phen)Cl].H2O	(3)	 14.2±0.34	 11.1±0.43 20.3±0.49 22.9±0.35	
[Mn(MPAPT)(1,10‐phen)Cl].H2O	(4)	 12.7±0.25	 10.1±0.25 18.8±0.57 21.8±0.39	
Standard	b	 17.3±0.15	 22.3±0.18 27.4±0.18 32.4±0.10	
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
b	The	standard	antibacterial	agents	are	Gentamicin	for	G(‐)	and	Ampicillin	for	G(+).	
	
	
Table	3.	Antifungal	activity	of	thiosemicarbazone	ligand	and	its	metal	complexes.	
Compounds	 Diameter	of	inhibition	zone	(in	mm)	a	
Aspergillus	flavus
(RCMB	02568)	
Pencicillium	italicum
(RCMB	03924)	
Geotricum	candidum
(RCMB	05097)	
MPAPT	 14.6±0.38		 15.4±0.24	 17.7±0.24	
[Cu(MPAPT)(1,10‐phen)Cl]	(1)	 19.6±0.50	 19.2±0.38 24.5±0.15	
[Ni(MPAPT)(1,10‐phen)Cl]	(2)		 17.8±0.28	 16.5±0.54 22.4±0.32	
[Co(MPAPT)(1,10‐phen)Cl].H2O	(3)	 16.6±0.45		 15.7±0.24	 20.6±0.75	
[Mn(MPAPT)(1,10‐phen)Cl].H2O	(4)	 15.6±0.37	 14.8±0.37	 17.8±0.73	
Amphotericin	(B)	 23.7±0.10	 21.9±0.12	 28.7±0.22	
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
	
	
3.5.	Biological	studies	
	
3.5.1.	Antimicrobial	activity	
	
To	 assess	 the	 biological	 potential	 of	 the	 synthesized	
compounds,	 the	 thiosemicarbazone	 ligand	 and	 its	 metal	
complexes	were	tested	against	different	species	of	bacteria	and	
fungi.	The	parent	(MPAPT)	ligand	and	its	complexes	are	water	
insoluble;	 therefore,	 the	 antimicrobial	 test	was	 carried	 out	 in	
DMSO.	The	results	of	the	antimicrobial	test	of	the	parent	ligand	
and	 its	 metal	 complexes	 against	 Gram	 positive	 and	 Gram	
negative	are	given	in	Table	2	while	the	results	of	the	antifungal	
activity	 against	 was	 given	 in	 Table	 3.	 In	 testing	 the	
antimicrobial	activity	of	these	compounds,	we	used	more	than	
one	test	organism	to	increase	the	chance	of	detecting	antibiotic	
principles	 in	 tested	 materials.	 The	 organisms	 used	 in	 the	
present	 investigations	 included	 two	 Gram	 positive	
(Staphylococcus	 aureus	 and	 Bacillus	 subtillis)	 and	 two	 Gram	
negative	 (Pseudomonas	aeruguinosa	and	Escherichia	 coli).	 The	
diffusion	agar	technique	was	used	to	evaluate	the	antibacterial	
activity	of	the	synthesized	mixed	ligand	complexes	[53‐56].	The	
medium	used	for	growing	the	culture	was	nutrient	agar.	Metal	
ions	 are	 adsorbed	 on	 the	 cell	 walls	 of	 the	 microorganisms,	
disturbing	 the	 respiration	 processes	 of	 the	 cells	 and	 thus	
blocking	 the	 protein	 synthesis	 that	 is	 required	 for	 further	
growth	of	the	organisms.	Hence,	metal	ions	are	essential	for	the	
growth‐inhibitory	 effects	 [57].	 The	 synthesized	 compounds	
were	 found	 to	 be	 more	 toxic	 compared	 with	 the	 parent	 free	
ligand	 against	 the	 same	 micro‐organism	 and	 under	 the	
identical	 experimental	 conditions.	 According	 to	 Overtone’s	
concept	 of	 cell	 permeability,	 the	 lipid	 membrane	 that	
surrounds	 the	 cell	 favors	 the	 passage	 of	 only	 lipid‐soluble	
materials,	so	lipophilicity	is	an	important	factor	controlling	the	
antifungal	activity.	Upon	chelating,	the	polarity	of	the	metal	ion	
will	 be	 reduced	 due	 to	 the	 overlap	 of	 the	 ligand	 orbitals	 and	
partial	 sharing	 of	 the	 positive	 charge	 of	 the	 metal	 ion	 with	
donor	 groups.	 In	 addition,	 chelation	 allows	 for	 the	
delocalization	 of	 π‐electrons	 over	 the	 entire	 chelate	 ring	 and	
enhances	 the	 lipophilicity	 of	 the	 complexes.	 This	 increased	
lipophilicity	 facilitates	 the	 penetration	 of	 the	 complexes	 into	
lipid	 membranes,	 further	 restricting	 proliferation	 of	 the	
microorganisms.	The	variation	 in	the	effectiveness	of	different	
compounds	against	different	organisms	depends	either	on	the	
impermeability	 of	 the	microbial	 cells	 or	 on	 differences	 in	 the	
ribosomes	of	the	cells	[58].	All	of	the	metal	complexes	possess	
higher	antifungal	activity	than	the	free	ligand	[59,60].	Although	
the	 exact	 biochemical	 mechanism	 is	 not	 completely	
understood,	 the	mode	of	 action	of	 antimicrobials	may	 involve	
various	 targets	 in	 the	 microorganisms.	 These	 targets	 include	
the	following.		
(i) The	 higher	 activity	 of	 the	 metal	 complexes	 may	 be	
due	to	the	different	properties	of	the	metal	ions	upon	chelation.	
The	 polarity	 of	 the	 metal	 ions	 will	 be	 reduced	 due	 to	 the	
overlap	of	the	ligand	orbitals	and	partial	sharing	of	the	positive	
charge	 of	 the	 metal	 ion	 with	 donor	 groups.	 Thus,	 chelation	
enhances	 the	 penetration	 of	 the	 complexes	 into	 lipid	
membranes	 and	 the	 blockage	 of	 metal	 binding	 sites	 in	 the	
enzymes	of	the	microorganisms	[61].		
(ii) Tweedy’s	 chelation	 theory	 predicts	 that	 chelation	
reduces	 the	 polarity	 of	 the	 metal	 atom	 mainly	 because	 of	
partial	 sharing	 of	 its	 positive	 charge	 with	 donor	 groups	 and	
possible	 electron	 delocalization	 over	 the	 entire	 ring.	 This	
consequently	increases	the	lipophilic	character	of	the	chelates,	
favoring	 their	 permeation	 through	 the	 lipid	 layers	 of	 the	
bacterial	membrane	[62].		
(iii) Interference	 with	 the	 synthesis	 of	 cellular	 walls,	
causing	damage	that	can	lead	to	altered	cell	permeability	
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Table	4.	Effect	of	synthesized	metal	complexes	on	tumor	cell	growth	in	vitro	(IC50	values	in	μg/mL).	
Compounds	 IC50	
HCT116 HEP2	
[Cu(MPAPT)(1,10‐phen)Cl]	(1)	 0.63 0.41	
[Ni(MPAPT)(1,10‐phen)Cl]	(2)		 0.91 0.66	
[Co(MPAPT)(1,10‐phen)Cl].H2O	(3)	 1.11 0.78	
[Mn(MPAPT)(1,10‐phen)Cl].H2O	(4)	 1.35 0.81	
Doxorubicin	(standard)	 0.69 0.40	
IC50	=cytotoxic	dose	at	50	%,	i.e.	the	drug	concentration	to	inhibit	the	growth	of	the	cancer	cells	by	50	%.	
	
	
characteristics	 or	 disorganized	 lipoprotein	 arrangements,	
ultimately	resulting	in	cell	death.		
(iv) Deactivation	 of	 various	 cellular	 enzymes	 that	 play	 a	
vital	role	in	the	metabolic	pathways	of	these	microorganisms.		
(v) Denaturation	 of	 one	 or	 more	 cellular	 proteins,	
causing	the	normal	cellular	processes	to	be	impaired.		
(vi) Formation	 of	 a	 hydrogen	 bond	 through	 the	
azomethine	 group	 with	 the	 active	 centers	 of	 various	 cellular	
constituents,	 resulting	 in	 interference	 with	 normal	 cellular	
processes	[63‐65].		
The	 tested	 complexes	 were	 more	 active	 against	 Gram(+)	
than	 Gram(‐)	 bacteria,	 it	 may	 be	 concluded	 that	 the	 antibac‐
terial	activity	of	the	compounds	is	related	to	cell	wall	structure	
of	the	bacteria.	It	is	possible	because	the	cell	wall	is	essential	to	
the	 survival	 of	 bacteria	 and	 some	 antibiotics	 are	 able	 to	 kill	
bacteria	by	 inhibiting	a	step	 in	the	synthesis	of	peptidoglycan.	
Gram‐positive	 bacteria	 possess	 a	 thick	 cell	 wall	 containing	
many	 layers	 of	 peptidoglycan	 and	 teichoic	 acids,	 but	 in	
contrast,	Gram	negative	bacteria	have	a	relatively	thin	cell	wall	
consisting	 of	 a	 few	 layers	 of	 peptidoglycan	 surrounded	 by	 a	
second	 lipid	 membrane	 containing	 lipopolysaccharides	 and	
lipoproteins.	 These	 differences	 in	 cell	 wall	 structure	 can	
produce	 differences	 in	 antibacterial	 susceptibility	 and	 some	
antibiotics	 can	 kill	 only	 Gram‐positive	 bacteria	 and	 is	
ineffective	against	Gram‐negative	pathogens	[66,67].	It	is	worth	
noting	 that	 the	 comparison	 of	 antimicrobial	 activity	 of	 the	
compounds	against	the	selected	types	of	bacteria	(Figure	1	and	
2)	indicates	that	Cu(II)		Ni(II)		Co(II)		Mn(II).		
	
	
Figure	1.	Antibacterial	activity	of	M(II)‐complexes	towards	different	types	of	
bacterial	strains.	
	
	
	
Figure	2.	 Antifungal	 activity	 of	M(II)‐complexes	 towards	 different	 types	 of	
fungal	strains.	
	
3.5.2.	Cytotoxic	activities	
	
Cytotoxic	study	of	the	compounds	against	Colon	Carcinoma	
(HCT116)	 and	 Larynx	 Carcinoma	 (HEP2)	 cells	 indicate	 that,	
[Cu(MPAPT)(1,10‐phen)Cl]	 complex	 show	 significant	 activity	
against	 (HCT116)	 and	 (HEP2)	 cells	 with	 IC50	 values	 of	 0.41	
g/ml	 (Figure	 3)	 and	 0.63	 g/mL	 respectively.	 Thus,	
[Cu(MPAPT)(1,10‐phen)Cl]	 complex	 is	 chemotherapeutically	
significant	(Table	4).	IC50	is	the	concentration	which	can	reduce	
the	 growth	 of	 cancer	 cells	 by	 50	 %.	 Results	 show	 that	 the	
growth	 inhibition	 of	 tumor	 cells	 is	 due	 to	 apoptosis	
(programmed	 cell	 death)	 in	 all	 M(II)‐complexes.	 Induction	 of	
apoptosis	was	recently	thought	to	be	one	of	the	mechanisms	of	
the	antitumor	effect	of	cis‐platin	[68].		
	
	
	
Figure	3.	Effect	of	Cu(II)	complex	on	surviving	fraction	of	HEP2	tumor	cell.
	
	
3.6.	Molecular	modeling	
	
The	atomic	numbering	scheme	as	given	in	Figures	4‐6	and	
the	theoretical	geometry	structures	for	the	ligand	and	some	of	
its	metal	complexes	are	calculated.	The	molecular	parameters:	
total	energy,	binding	energy,	isolated	atomic	energy,	electronic	
energy,	 heat	 of	 formation,	 dipole	 moment,	 HOMO	 and	 LUMO	
were	 calculated	 and	 represented	 in	 Table	 5.	 A	 comparison	
between	 the	 bond	 length	 of	 the	 ligand	 and	 its	 complexes	 is	
illustrated.	 All	 the	 active	 groups	 taking	 part	 in	 coordination	
have	 bonds	 longer	 than	 that	 already	 exist	 in	 the	 ligand	 (like	
C=N	 and	 C=S).	 The	 lower	 HOMO	 energy	 values	 show	 that	
molecule	donating	electron	ability	 is	 the	weaker.	On	 contrary,	
the	 higher	 HOMO	 energy	 implies	 that	 the	molecule	 is	 a	 good	
electron	donor.	LUMO	energy	presents	the	ability	of	a	molecule	
receiving	electron	[69].		
	
	
	
Figure	4.	The	optimized	structural	geometry	of	MPAPT	along	with	the	atom	
numbering	scheme.	
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Table	5.	Some	energetic	properties	of	MPAPT	thiosemicarbazone	and	its	complexes	calculated	by	PM3	method.	
Ligand	 Total	energy	
(kcal/mol)	
Binding	energy	
(kcal/mol)	
Electronic	energy	
(kcal/mol)	
Dipole	moment	
(Debye)	
HOMO	
(eV)	
LUMO	
(eV)	
MPAPT	 ‐60965.8	 ‐3093.26	 ‐4001356.6	 4.55	 ‐8.94	 ‐1.51	
[Cu(MPAPT)(1,10‐phen)Cl]	(1)	 ‐138355.50	 ‐5845.52	 ‐1299306.8	 7.91	 ‐3.95	 ‐1.45	
[Ni(MPAPT)(1,10‐phen)Cl]	(2)		 ‐135067.27	 ‐5967.66	 ‐1268318.8	 19.47	 ‐6.36	 ‐2.29	
[Co(MPAPT)(1,10‐phen)Cl].H2O	(3)	 ‐129390.70	 ‐6156.55	 ‐1231416.2	 8.50	 ‐3.62	 ‐1.55	
[Mn(MPAPT)(1,10‐phen)Cl].H2O	(4)	 ‐120098.41	 ‐5907.57 ‐1181854.9 10.19 ‐4.30	 ‐1.31
	
	
	
	
Figure	5.	The	optimized	structural	 geometry	of	 [Co(MPAPT)(1,10‐phen)Cl]	
(3)	along	with	the	atom	numbering	scheme.	
	
	
	
	
Figure	6.	The	optimized	structural	geometry	of	[Mn(MPAPT)(1,10‐phen)Cl]	
(4)	along	with	the	atom	numbering	scheme.	
	
The	 bond	 lengths	 and	 bond	 angles	 of	 [Co(MPAPT)(1,10‐
phen)Cl]	 complex	 as	 a	 representative	 example	 of	 M(II)	
compounds	 are	 given	 in	 supplementary	 data.	 A	 drawing	 of	
MPAPT‐thiosemicarbazone	 ligand	 is	 shown	 in	 Figure	 4	 while	
Co(II)	and	Ni(II)	complexes	with	the	atomic	numbering	scheme	
are	 shown	 in	Figures	5	and	6.	The	 coordination	 results	 in	 the	
changes	 of	 bond	 lengths	 and	 angles	 of	 the	 thiosemicarbazone	
moiety,	 as	 expected,	 thus	 when	 the	 bond	 lengths	 in	 the	
coordinated	 thiosemicarbazone	 ligand	 are	 compared	 with	
those	 in	 the	 free	 thiosemicarbazone	 ligand,	 it	 is	 seen	 that	
coordination	 elongates	 the	 thiosemicarbazone	 moiety’s	 C–S	
bond	from	1.664	Å	to	1.709‐1.787	Å	and	contracts	adjacent	N–
C(S)	bond	from	1.420	Å	to	1.325‐1.347	Å	in	which	is	consistent	
with	 the	 C–S	 acquiring	 a	 partial	 single	 bond	 and	 N–C(S)	 a	
partial	double	bond	 character.	These	 changes	 in	bond	 lengths	
are	attributable	to	stabilization	of	the	iminothiolate	form	of	the	
thiosemicarbazone	 ligand	 upon	 complexation	 via	 loss	 of	 the	
hydrazinic	 proton	 [70].	 This	means	 that,	 C–S	 distances	which	
are	 in	 the	 range	 of	 single	 bond	 character	 being	 some	 of	 the	
largest	 found	 for	M(II)	 complexes	 (typical	 bond	 lengths	being	
C(sp2)–S	 1.706	 Å	 in	 (MeS)2C=C(SMe)2	 and	 C=S	 1.630	 Å	 in	
naphthylphenylthioketone)	 [71,72].	 This	 also	 confirms	 the	 IR	
and	spectral	data	which	assumed	that	the	C=S	on	coordination	
gains	C–S	character.	 Similar	 structural	 features	 are	known	 for	
other	 metal	 complexes	 of	 such	 ligands	 that	 have	 the	 same	
coordination	sites	 [70,73].	 The	other	bond	 lengths	 and	angles	
also	 suffer	 some	changes,	but	not	 significantly.	 In	general,	 the	
M–S	 bond	 length	 is	 longer	 than	 that	 of	M–Cl	 for	 the	 all	M(II)	
complexes	and	the	M–N	bond	length	is	shorter	than	M–Cl	bond	
length	showing	 that	 the	bond	 length	obeyed	 this	order	M–S	>	
M–Cl	 >	 M–N.	 In	 all	 complexes,	 C=Npy	 bond	 distance	 of	 the	
pyridine	 ring	 is	elongated.	Owing	 to	 the	 formation	of	 the	M‐N	
bond	 which	 makes	 the	 C=N	 bond	 weaker	 as	 a	 result	 of	
coordination.	The	bond	angles	of	the	thiosemicarbazone	moiety	
of	MPAPT	are	altered	somewhat	upon	coordination	and	may	be	
reduced	or	 increased	on	complex	 formation	as	a	 consequence	
of	 bonding.	 The	 bond	 angles	 around	 the	M(II)	 center	 (≃90	 °)	
prove	 that	 the	 geometric	 is	 octahedral	 as	 proposed	 by	 the	
different	 tools	 of	 analysis	mentioned	previously.	 Finally,	 from	
the	interpretation	of	elemental	analysis,	spectral	data	(infrared,	
electronic	and	ESR)	as	well	as	magnetic	susceptibility	measure‐
ments	 at	 room	 temperature,	 conductivity	 measurements	 and	
QM	 calculations,	 it	 is	 possible	 to	 draw	 up	 the	 tentative	
octahedral	structures	of	the	metal	complexes.	
	
4.	Conclusions	
	
The	 condensation	 reaction	 of	 4‐(2‐pyridyl)‐3‐thiosemi‐
carbazone	 with	 1‐methyl‐1H‐pyrazole‐5‐carbox‐aldehyde	 in	
the	 molar	 ratio	 (1:1)	 afforded	 the	 corresponding																											
1‐methylpyrazole‐3‐aldehyde‐4‐(2‐pyridyl)thiosemicarbazone	
compound	(MPAPT).	The	bonding	of	ligands	to	the	metal	ion	is	
confirmed	by	analytical,	spectral	and	magnetic	measurements.	
The	 IR	 spectra	 showed	 that,	 thiosemicarbazone	 compound	
present	in	the	thione	form	in	the	solid	state.	In	the	absence	of	X‐
ray	 single	 crystal	 data	 of	 the	 current	 synthesized	 complexes	
and	 based	 on	 the	 physicochemical	 studies	 and	 geometrical	
optimization,	a	tentative	structure	could	be	proposed	as	shown	
in	Figures	4‐6.	M(II)‐complexes	are	 formulated	as	 [M(MPAPT)	
(1,10‐phen)Cl].nH2O	 where	 MPAPT	 is	 the	 deprotonated	
thiosemicarbazone	 ligand.	 In	 these	 complexes	 the	 thiosemi‐
carbazone	 ligand	 is	 coordinated	 to	 the	 metal(II)	 ion	 as	 a	
tridentate	 anion,	 coordinating	 via	 the	 azomethine	 nitrogen,	
pyridine	 nitrogen	 atoms	 and	 the	 thiolate	 sulfur	 atom	 after	
deprotonation.	 1,10‐Phen	 is	 coordinated	 as	 neutral	 bidentate	
ligand	via	the	two	pyridine	nitrogen	atoms.		
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From	 elemental	 analysis,	 IR,	 spectral,	 thermal	 analysis,	
magnetic	and	conductance	measurements,	all	M(II)‐complexes	
are	 nonelectrolytes	with	 octahedral	 structure.	 In	 this	work,	 it	
was	 found	 that	 the	 M(II)	 compounds	 show	 significantly	
different	 levels	 of	 biological	 activity.	 The	 antibacterial,	
antifungal,	 screening	 data	 revealed	 that	 newly	 generated	
compounds	are	potential	 antimicrobial	 agents.	Cu(II)	 complex	
showed	a	higher	antitumor	activity	versus	larynx	carcinoma.	
	
Supplementary	material	
	
Supporting	 information	 for	 this	 article	 is	 available	 on	 the	
WWW	under	http://www.eurjchem.com	or	from	author.	 	 	The	
bond	 lengths	 and	 bond	 angles	 of	 [Co(MPAPT)(1,10‐phen)Cl]	
complex	 as	 a	 representative	 example	 of	M(II)	 compounds	 are	
given	in	Table	S1. 	
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